Overview of Dr. Sanchez
Carlos E. Sanchez, MD, FAANS is a board certified neurosurgeon and a principal investigator at the Cell Enhancement and Technologies for Immunotherapy Program at the George Washington University Cancer Center. He specializes in surgical care for patients with benign and malignant brain tumors and CSF disorders. Fellowship trained in pediatric neurosurgery, Dr. Sanchez served as the director of skull base surgery at Children’s National Hospital from 2018-2021 and specializes in caring young adult and adult patients with neurosurgical conditions previously treated in childhood.
During his neurosurgery residency at the University of New Mexico, he pursued a CAST-certified fellowship in Neurocritical Care. He then completed a fellowship in Pediatric Neurosurgery at UCSD/Rady Children’s Hospital under the guidance of Michael Levy, MD, Ph.D.
Dr. Sanchez completed his scientific training at Massachusetts General Hospital under the guidance of Bob Carter, MD, Ph.D., where he was a Ruth L. Kirschstein National Research Award Scholar. He subsequently was awarded a three-year NIH KL2 award through the Clinical and Translational Science Institute at Children’s National, under the mentorship of Catherine Bollard, MD, MBChB. His scientific focus is the development of adoptive cell therapy technologies for brain tumors. Dr. Sanchez is a S.G.E. and serves as a consultant to the FDA, for the Cellular Tissue and Gene Therapies Advisory Committee (CTGTAC).
Beyond his clinical work, Dr. Sanchez serves on the Board of Advisors for Columbia University, Mailman School of Public Health and sits on the Health Equity Committee.
Office
2150 Pennsylvania Ave, NW
Dept. of Neurosurgery, 7th Floor
Washington, DC 20037Fax+1 202-741-2742- Is this information wrong?
Education & Training
- University of California (San Diego) Medical CenterFellowship, Pediatric Neurosurgery, 2017 - 2018
- University of New Mexico School of MedicineResidency, Neurological Surgery, 2011 - 2017
- University of New Mexico School of MedicineNeuroCritical Care, 2015 - 2016
- Massachusetts General HospitalPost-Doctoral Fellowship, Surgical Oncology, Adoptive Immunotherapy, 2006 - 2010
- St. George's University School of MedicineClass of 2005
Certifications & Licensure
- MD State Medical License 2018 - 2025
- DC State Medical License 2018 - 2024
- VA State Medical License 2018 - 2024
- CA State Medical License 2017 - 2019
- NM State Medical License 2010 - 2017
Awards, Honors, & Recognition
- NIH KL2 Grant Award Clinical and Translational Science Institute at Children’s National
- National Research Scholar Award National Institute of Health
Publications & Presentations
PubMed
- 15 citationsLong-term outcomes for children with an incidentally discovered Chiari malformation type 1: what is the clinical significance?Laurence Davidson, Tiffany N Phan, John S. Myseros, Suresh N. Magge, Chima O. Oluigbo
Child's Nervous System. 2021-04-01 - 14 citationsNK Cell Adoptive Immunotherapy of Cancer: Evaluating Recognition Strategies and Overcoming Limitations.Carlos E. Sanchez, Ehsan P. Dowlati, Ashley Geiger, Kajal Chaudhry, Matthew A. Tovar
Transplantation and Cellular Therapy. 2021-01-01 - 3 citationsRate-controlled intraventricular endoscopic irrigation via bipolar foot pedal activation: technical note.Reid Hoshide, Robert C. Rennert, Carlos E Sanchez, Joel R. Martin, Vincent J Cheung
Journal of Neurosurgery. Pediatrics. 2020-04-01
Books/Book Chapters
Professional Memberships
- Member
- Member
- Pediatric Section
- American Association of Neurological SurgeonsPediatric Section, Member
Other Languages
- Spanish
Hospital Affiliations
- George Washington University HospitalWashington, District of Columbia
External Links
- Children's Nationalhttps://childrensnational.org/choose-childrens/find-a-provider/carlos-sanchez
- LinkedInhttps://www.linkedin.com/in/carlos-sanchez-m-d-9340934/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: